Blog
IPO News | US Stock Market Preview This Week: 6 Companies to Go Public

Review: Last week, 6 IPOs completed their listings, among which 4 had a fundraising scale exceeding $100 million.
Nextracker (NXT) issued 26.6 million shares at $24 per share, raising $638 million, making it the largest IPO in the U.S. so far this year. Hesai (HSAI) issued 10 million shares at $19 per share, raising $190 million. Mineralys (MLYS) issued 12 million shares at $16 per share, raising $192 million. Enlight Renewable (ENLT) raised $252 million. Lucy Scientific Discovery (LSDI) issued 1.875 million shares at $4 per share, raising $7.5 million. Richson China (LICN) issued 4 million shares at $4 per share, raising $16 million.
This week, 6 IPOs are scheduled to list, with a fundraising scale of approximately $70 million.
1. Biotechnology — Intensity Therapeutics, Inc.
Intensity Therapeutics was founded in 2012 and is a clinical-stage biotechnology company. The company's main candidate drugs are undergoing Phase 2 trials, one for advanced diseases and another for early-stage breast cancer, and are expected to enter Phase 3 trials for advanced soft tissue sarcoma and neoadjuvant breast cancer by the end of 2023 or early 2024.
Fundraising scale
The company plans an IPO offering price of $4.5 per share, issuing 1.78 million shares, with a fundraising scale of approximately $8 million.
Financial data
The company has no revenue yet.
2. Drug development platform — BullFrog AI Holdings, Inc.
Bullfrog AI was founded in 2017 and is a company that uses artificial intelligence and machine learning (AI/ML) to improve drugs for internal and external projects. Its AI/ML platform (bfLEAP) was initially created using technology developed by the Johns Hopkins University Applied Physics Laboratory (JHU-APL).
Fundraising Size
The company plans an IPO with an offering price of $6.50, issuing 1.32 million shares, for a fundraising size of approximately $8.6 million.
Financial Data
The company has no revenue yet.
3. Infectious Disease Biotechnology Company — Alopexx, Inc.
Alopexx was founded in 2021 and is a clinical-stage biotechnology company focused on developing novel broad-spectrum immune-mediated therapies for the prevention and treatment of a wide range of bacterial, fungal, and parasitic microbial infections.
Fundraising Size
The company plans an IPO with an offering price of $5, issuing 3 million shares, for a fundraising size of approximately $15 million.
Financial Data
Alopexx has no revenue yet.
4. Fitness Equipment Brand — Interactive Strength, Inc.
Interactive Strength was founded in 2017 and is a company that sells home fitness equipment. Under the Forme brand, it offers two connected fitness hardware products: Forme Studio (fitness mirror) and Forme Studio Lift (related product for the fitness mirror).
Fundraising Size
The company plans an IPO with an offering range between $6 and $8, issuing 2 million shares, for a maximum fundraising of approximately $16 million.
Financial Data
In the first nine months of 2022, the company's revenue was $490,000, compared to $160,000 in the same period of the previous year, and the corresponding net losses during this period were $39.42 million and $19.8 million respectively.
5. Game Platform Developer — The NFT Gaming Company, Inc.
The NFT Gaming is a digital game platform dedicated to developing various types of digital games. The company also plans to integrate non-fungible tokens into the games on the platform.
Fundraising Scale
The company plans to set the IPO offering price at $4.15, issuing 1.69 million shares, with a fundraising scale of approximately $7 million.
Financial Data
The company has no revenue yet.
6. Japanese Real Estate Company — SYLA Technologies Co., Ltd.
SYLA Technologies is a real estate developer engaged in real estate leasing, brokerage and management, as well as the operation and maintenance of solar power plants.
Fundraising Scale
The company plans to set the IPO offering price at $8, issuing 1.88 million shares, with a fundraising scale of approximately $15 million.
Financial Data
For the 2020-2021 fiscal years, the company's revenue was $96.8 million and $123 million respectively, and the corresponding net profits during this period were $3.21 million and $2.05 million respectively.
Originally published on 金盒企业管理集团




